Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : A US National Health Care System? -- Ignore unavailable to you. Want to Upgrade?

To: Archie Meeties who wrote (11207)	11/10/2009 10:11:19 AM
From: jrhana	Read Replies (1) \| Respond to of 42652

Good article <“I think the physician community has to take some ownership responsibility and do their own due diligence beyond the sales and marketing person,” says Boston’s former U.S. Attorney Michael Sullivan.> <A Morass’ “It’s a morass of undifferentiated information out there,” Public Citizen’s Lurie says. “And the doctors, let alone patients, aren’t able to distinguish the good from the bad.” One thing all people should do, Lurie says, is ask whether their prescriptions are for FDA-approved uses, and if not, whether strong evidence supports using the drug, particularly if it can be dangerous.> Definitely off label uses can be legitimate. However, if the patient has a drug reaction after an off label use, then he could face some legal liability. I would hope that the worst abuses are ending. The physician must be supplied unbiased data and opinions to base his prescribing on. Luckily now with the internet this is much easier. I remember finding this very user friendly and a great source of information. uptodate.com